- Home
- FBYD vs CRMD Comparison
FBYD vs CRMD Comparison
Compare FBYD & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FBYD | CRMD |
|---|---|---|
| Founded | 2021 | 2006 |
| Country | United States | United States |
| Employees | 243 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 868.0M | 695.9M |
| IPO Year | N/A | 2009 |
Fundamental Metrics
Financial Performance| Metric | FBYD | CRMD |
|---|---|---|
| Price | $10.64 | $7.87 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $14.83 |
| AVG Volume (30 Days) | 211.8K | ★ 1.2M |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 780.00 |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | ★ $311,709,000.00 |
| Revenue This Year | N/A | $0.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $268.88 | ★ $18.72 |
| Revenue Growth | N/A | ★ 617.03 |
| 52 Week Low | $3.71 | $6.13 |
| 52 Week High | $29.02 | $14.96 |
Technical Indicators
Market Signals| Indicator | FBYD | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 37.35 | 42.72 |
| Support Level | $10.06 | $7.50 |
| Resistance Level | $12.88 | $9.02 |
| Average True Range (ATR) | 1.81 | 0.34 |
| MACD | -0.52 | -0.07 |
| Stochastic Oscillator | 12.44 | 13.57 |
Price Performance
Historical ComparisonAbout FBYD Falcon's Beyond Global Inc.
Falcons Beyond Global Inc is a visionary entertainment and technology enterprise. The group designs, develops, engineers, delivers, and commercializes immersive physical and digital experiences for brands, developers, and destination operators world-wide, as well as for its own portfolio of entertainment and technology concepts. The Company has five operating segments: Falcon's Creative Group, Destinations Operations, PDP, Falcon's Beyond Brands, and Falcon's Attractions. It earns the majority of the revenue from Falcon's Creative Group segment.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.